Last reviewed · How we verify
Randomization between two referenced treatments
Randomization between two referenced treatments is a Small molecule drug developed by University Hospital, Clermont-Ferrand. It is currently FDA-approved.
Randomization is a method used in clinical trials to compare two or more treatments, such as Clindamycin 1% / Benzoyl Peroxide 5% (Perrigo) and Clindamycin 1% / Benzoyl Peroxide 5% (Benzaclin), by assigning participants to each treatment group randomly. This method, as seen in the clinical trial NCT01138514, helps to minimize bias and ensure that the groups being compared are similar in terms of demographic and clinical characteristics.
At a glance
| Generic name | Randomization between two referenced treatments |
|---|---|
| Sponsor | University Hospital, Clermont-Ferrand |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Upper Limb Rehabilitation Using Non-invasive Spinal Cord Stimulation (NA)
- Effect of Soundscapes on Emotional Distress in Fibromyalgia: a 4×4 Crossover Trial (NA)
- The Influence of Chemotherapy on Position Sense
- Pilates and Aerobic Training on Cardiorespiratory Fitness, Flexibility, Strength, and Muscular Power in Young Adults (NA)
- PILATES AND AEROBIC TRAINING ON BODY COMPOSITION IN YOUNG ADULTS (NA)
- A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants (PHASE1)
- A Study to Evaluate Two Vonoprazan Orally Disintegrating Tablet Formulations Administered Without Water or Mixed With Water and Administered Via a Syringe Relative to the Vonoprazan Tablet in Healthy Participants (PHASE1)
- Impact of Auditory Environments on Pain in Fibromyalgia: a 4×4 Crossover Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Randomization between two referenced treatments CI brief — competitive landscape report
- Randomization between two referenced treatments updates RSS · CI watch RSS
- University Hospital, Clermont-Ferrand portfolio CI
Frequently asked questions about Randomization between two referenced treatments
What is Randomization between two referenced treatments?
Who makes Randomization between two referenced treatments?
What development phase is Randomization between two referenced treatments in?
Related
- Manufacturer: University Hospital, Clermont-Ferrand — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing